Literature DB >> 28648873

Breast Cancer Screening for Average-Risk Women: Recommendations From the ACR Commission on Breast Imaging.

Debra L Monticciolo1, Mary S Newell2, R Edward Hendrick3, Mark A Helvie4, Linda Moy5, Barbara Monsees6, Daniel B Kopans7, Peter R Eby8, Edward A Sickles9.   

Abstract

Breast cancer is the most common non-skin cancer and the second leading cause of cancer death for women in the United States. Before the introduction of widespread mammographic screening in the mid-1980s, the death rate from breast cancer in the US had remained unchanged for more than 4 decades. Since 1990, the death rate has declined by at least 38%. Much of this change is attributed to early detection with mammography. ACR breast cancer screening experts have reviewed data from RCTs, observational studies, US screening data, and other peer-reviewed literature to update our recommendations. Mammography screening has consistently been shown to significantly reduce breast cancer mortality over a variety of study designs. The ACR recommends annual mammography screening starting at age 40 for women of average risk of developing breast cancer. Our recommendation is based on maximizing proven benefits, which include a substantial reduction in breast cancer mortality afforded by regular screening and improved treatment options for those diagnosed with breast cancer. The risks associated with mammography screening are also considered to assist women in making an informed choice.
Copyright © 2017 American College of Radiology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Breast cancer screening; breast cancer; early detection; mammography; mammography screening

Mesh:

Year:  2017        PMID: 28648873     DOI: 10.1016/j.jacr.2017.06.001

Source DB:  PubMed          Journal:  J Am Coll Radiol        ISSN: 1546-1440            Impact factor:   5.532


  47 in total

1.  Breast cancer tumor histopathology, stage at presentation, and treatment in the extremes of age.

Authors:  Jennifer K Plichta; Samantha M Thomas; Rebecca Vernon; Oluwadamilola M Fayanju; Laura H Rosenberger; Terry Hyslop; E Shelley Hwang; Rachel A Greenup
Journal:  Breast Cancer Res Treat       Date:  2020-01-24       Impact factor: 4.872

2.  Breast cancer screening: in the era of personalized medicine, age is just a number.

Authors:  Andrea Cozzi; Simone Schiaffino; Paolo Giorgi Rossi; Francesco Sardanelli
Journal:  Quant Imaging Med Surg       Date:  2020-12

Review 3.  Bayes' formula: a powerful but counterintuitive tool for medical decision-making.

Authors:  M P K Webb; D Sidebotham
Journal:  BJA Educ       Date:  2020-04-19

4.  Effect of Screening Mammography on Other Preventive Services in Older Women.

Authors:  Gary J Whitman; Scott B Cantor
Journal:  Radiology       Date:  2018-06-05       Impact factor: 11.105

Review 5.  Abbreviated MR Imaging for Breast Cancer.

Authors:  Laura Heacock; Alana A Lewin; Hildegard K Toth; Linda Moy; Beatriu Reig
Journal:  Radiol Clin North Am       Date:  2020-11-02       Impact factor: 2.303

6.  Using Facebook Live to Advocate Breast Cancer Screening.

Authors:  Hilda H Tso; Jay R Parikh
Journal:  J Digit Imaging       Date:  2020-08       Impact factor: 4.056

7.  Cost-effectiveness of mammography from a publicly funded health care system perspective.

Authors:  Nicole Mittmann; Natasha K Stout; Anna N A Tosteson; Amy Trentham-Dietz; Oguzhan Alagoz; Martin J Yaffe
Journal:  CMAJ Open       Date:  2018-02-08

Review 8.  Procalcitonin: Where Are We Now?

Authors:  Bachar Hamade; David T Huang
Journal:  Crit Care Clin       Date:  2019-10-21       Impact factor: 3.598

9.  Mammography use and breast cancer incidence among older U.S. women.

Authors:  Sara D Turbow; Mary C White; Erica S Breslau; Susan A Sabatino
Journal:  Breast Cancer Res Treat       Date:  2021-03-05       Impact factor: 4.872

10.  Prospective Study of Psychosocial Outcomes of Having Contralateral Prophylactic Mastectomy Among Women With Nonhereditary Breast Cancer.

Authors:  Patricia A Parker; Susan K Peterson; Yu Shen; Isabelle Bedrosian; Dalliah M Black; Alastair M Thompson; Jonathan C Nelson; Sarah M DeSnyder; Robert L Cook; Kelly K Hunt; Robert J Volk; Scott B Cantor; Wenli Dong; Abenaa M Brewster
Journal:  J Clin Oncol       Date:  2018-07-25       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.